{
    "clinical_study": {
        "@rank": "144576", 
        "arm_group": {
            "arm_group_label": "Patients requiring naloxone for respiratory depression"
        }, 
        "brief_summary": {
            "textblock": "Opioids are the mainstay of analgesia in hospitalized children but opioid therapy is\n      associated with life-threatening respiratory depression requiring antagonism with naloxone.\n      Hence, it is hypothesized that naloxone requirement can be used as a quality measure of\n      opioid safety. A retrospective medical chart review of 95 patients, who received naloxone\n      for life threatening events, from June 2006-2012, is planned, to identify significant\n      factors associated with risk for opioid induced respiratory depression and formulation of\n      preventive strategies."
        }, 
        "brief_title": "Critical Respiratory Events in Children Requiring Naloxone: Naloxone Use as Opioid Safety Measure", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "condition": "Opioid Induced Respiratory Depression", 
        "condition_browse": {
            "mesh_term": [
                "Depression", 
                "Depressive Disorder", 
                "Respiratory Insufficiency"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  any gender, age or race\n\n          -  administered naloxone for opioid induced respiratory depression\n\n        Exclusion Criteria:\n\n          -  Any one who did not require naloxone for opioid induced respiratory depression"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "All patients who required rescue with naloxone between June 2006 and June 2012; identified\n        based upon an automated trigger report generated from the hospital's risk management\n        database for any dispensation of naloxone from the hospital pharmacy"
            }
        }, 
        "enrollment": {
            "#text": "95", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01860885", 
            "org_study_id": "CIN1-2012-1219"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Naloxone", 
                "Analgesics, Opioid"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "naloxone", 
            "children", 
            "opioid", 
            "respiratory depression", 
            "safety"
        ], 
        "lastchanged_date": "May 21, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Cincinnati", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "45229"
                }, 
                "name": "Cincinnati Children's Hospital Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Study of Hospital-wide Critical Respiratory Events Requiring Naloxone in a Pediatric Institution", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Data leading to the event and post-event descriptives will be collected", 
            "measure": "Descriptive: Medical history and Risk Factors for critical respiratory events requiring Naloxone in children", 
            "safety_issue": "Yes", 
            "time_frame": "about 6 hours around the event"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01860885"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Children's Hospital Medical Center, Cincinnati", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Children's Hospital Medical Center, Cincinnati", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "May 2013"
    }
}